Psychiatrictimes

Published November 12, 2026

FDA Shelves Fast-Track Drug Review Initiative | Psychiatric Times

Read the full story at Psychiatrictimes

Amongst the top candidates were psychedelics such as psilocybin for treatment-resistant depression and major depressive disorder, and methylone.